Generic Versions of Levofloxacin Approved
Antibiotic prescribed for infections of sinuses, kidneys or bladder
MONDAY, June 20 (HealthDay News) -- The first generic versions of levofloxacin, prescribed under the brand name Levaquin, have been approved by the U.S. Food and Drug Administration.
The antibiotic is sanctioned for infections of the skin, sinuses, kidneys, bladder or prostate, as well as certain strains of bacterial bronchitis or pneumonia, the agency said in a news release.
The generic versions, licensed to be produced by 12 manufacturers, is chemically equivalent to the brand-name drug. It belongs to a class of drugs called fluoroquinolones, which have a boxed label warning for increased risk of tendonitis and tendon rupture. The risk is higher among people 60 and older, among people who take corticosteroid drugs, and among people who have had kidney, heart or lung transplants, the FDA said.
To learn more about this drug, visit the U.S. National Library of Medicine.Scott Roberts Related Articles
- FDA Renews Warning on HeartStart Defibrillator Failures
December 04, 2013
- Graphic Warnings on Cigarette Packs May Cut Smoking Rates: Study
December 02, 2013
Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.
Copyright © 2011 HealthDay. All rights reserved.